EUVIMEDEUVIMED entdecken
Übersichtsarbeit

AMPK/mTOR pathway significance in healthy liver and non‐alcoholic fatty liver disease and its progression

Ilitch Aquino Marcondes-de-Castro iD, Pedro Henrique Reis-Barbosa iD, Thatiany Souza Marinho iD, Marcia Barbosa Aguila iD, Carlos Alberto Mandarim-de-Lacerda iD

Journal of Gastroenterology and Hepatology · 2023-11 · 38 (11) · 1868-1876

DOI: 10.1111/jgh.16272 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 12.07.2023. Verfasst von Ilitch Aquino Marcondes-de-Castro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Morphometry, Metabolism, and Cardiovascular Diseases, Biomedical Centre, Institute of Biology, Rio de Janeiro State University, Rio de …. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 109-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is related to several organs, but the liver is particularly affected. Adenosine monophosphate‐activated protein kinase (AMPK) is a cellular energy sensor and regulator of liver lipid dysfunction and glucose metabolism. The mechanistic target of rapamycin (mTOR) is a protein kinase regulating cell growth, survival, metabolism, and immunity. Together, these pathways are involved in obesity, insulin resistance, non‐alcoholic fatty liver disease (NAFLD) and its progression, and autophagy. During energy demand, liver kinase B (LKB) phosphorylation helps activate the AMPK/mTOR pathways. Likewise, the protein forkhead box O family (FOXO) negatively regulates adipogenesis by binding to the promoter sites of peroxisome proliferator‐activated receptor‐gamma coactivator 1‐alpha, initiating adipogenesis. In addition, acetyl‐CoA carboxylase, which regulates de novo lipogenesis, is linked to LKB and FOXO in developing NAFLD. The kinase complex, consisting of Unc‐51‐like autophagy‐activating kinase 1 or 2 (ULK1, ULK2) by stimulating autophagy, and eliminating fat droplets in NAFLD, is regulated by mTORC1 and negatively regulated by AMPK that suppresses liver lipogenesis and increases fatty acid oxidation. Also, ULK1 is essential for initiating phagophore formation, establishing macrophagy, and generating autophagosomes. The selective breakdown of lipid droplets through macroautophagy, or macrolipophagy, occurs on a cellular energy level using free fatty acids. In addition, mTORC1 promotes lipogenesis by activating sterol regulatory element‐binding protein. Finding new components and novel regulatory modes in signaling is significant for a better understanding of the AMPK/mTOR pathways, potentially facilitating the development of future diagnostic and therapeutic strategies for NAFLD and its progression to non‐alcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseHumansAMP-Activated Protein KinasesLiverTOR Serine-Threonine KinasesObesityMechanistic Target of Rapamycin Complex 1

Stichwörter der Autor:innen

AMPK/mTOR pathwayautophagylipid metabolismnon-alcoholic fatty liver diseaseobesity

Substanzen

AMP-Activated Protein KinasesTOR Serine-Threonine KinasesMechanistic Target of Rapamycin Complex 1

Autor:innen und Institutionen

  • Laboratory of Morphometry, Metabolism, and Cardiovascular Diseases, Biomedical Centre, Institute of Biology, Rio de Janeiro State University, Rio de Janeiro, Brazil.

ORCID-Profile: Ilitch Aquino Marcondes-de-Castro, Pedro Henrique Reis-Barbosa, Thatiany Souza Marinho, Marcia Barbosa Aguila, Carlos Alberto Mandarim-de-Lacerda

Förderung

  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Marcondes-de-Castro, I. A., Reis-Barbosa, P. H., Marinho, T. S., Aguila, M. B., & Mandarim-de-Lacerda, C. A. (2023). AMPK/mTOR pathway significance in healthy liver and non‐alcoholic fatty liver disease and its progression. Journal of Gastroenterology and Hepatology, 38(11), 1868-1876. https://doi.org/10.1111/jgh.16272

Vancouver

Marcondes-de-Castro IA, Reis-Barbosa PH, Marinho TS, Aguila MB, Mandarim-de-Lacerda CA. AMPK/mTOR pathway significance in healthy liver and non‐alcoholic fatty liver disease and its progression. Journal of Gastroenterology and Hepatology. 2023;38(11):1868-1876. doi:10.1111/jgh.16272

BibTeX
@article{MarcondesdeCastro2023,
  author = {Marcondes-de-Castro, Ilitch Aquino and Reis-Barbosa, Pedro Henrique and Marinho, Thatiany Souza and Aguila, Marcia Barbosa and Mandarim-de-Lacerda, Carlos Alberto},
  title = {AMPK/mTOR pathway significance in healthy liver and non‐alcoholic fatty liver disease and its progression},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2023},
  volume = {38},
  number = {11},
  pages = {1868--1876},
  doi = {10.1111/jgh.16272}
}
Kostenlos starten →